NDC product
tizanidine hydrochloride
NDC 70710-1112 · Zydus Pharmaceuticals (USA) Inc.
Key facts
| Product NDC | 70710-1112 |
|---|---|
| Proprietary name | tizanidine hydrochloride |
| Nonproprietary name | tizanidine hydrochloride |
| Substances | TIZANIDINE HYDROCHLORIDE |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | Zydus Pharmaceuticals (USA) Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA208622 |
| Pharmacologic classes | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| Marketing start | Apr 27, 2017 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: